97 related articles for article (PubMed ID: 31653713)
1. Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure-Overload Heart Failure.
Glasenapp A; Derlin K; Wang Y; Bankstahl M; Meier M; Wollert KC; Bengel FM; Thackeray JT
J Nucl Med; 2020 Apr; 61(4):590-596. PubMed ID: 31653713
[TBL] [Abstract][Full Text] [Related]
2. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling.
Yamaguchi N; Xiao J; Narke D; Shaheen D; Lin X; Offerman E; Khodadadi-Jamayran A; Shekhar A; Choy A; Wass SY; Van Wagoner DR; Chung MK; Park DS
Circulation; 2021 Feb; 143(8):805-820. PubMed ID: 33225722
[TBL] [Abstract][Full Text] [Related]
4. Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene.
Huo S; Shi W; Ma H; Yan D; Luo P; Guo J; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
Oxid Med Cell Longev; 2021; 2021():6699054. PubMed ID: 33824698
[TBL] [Abstract][Full Text] [Related]
5. IL-12α deficiency attenuates pressure overload-induced cardiac inflammation, hypertrophy, dysfunction, and heart failure progression.
Bhattarai U; He X; Xu R; Liu X; Pan L; Sun Y; Chen JX; Chen Y
Front Immunol; 2023; 14():1105664. PubMed ID: 36860846
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NK1.1 signaling attenuates pressure overload-induced heart failure, and consequent pulmonary inflammation and remodeling.
He X; Xu R; Pan L; Bhattarai U; Liu X; Zeng H; Chen JX; Hall ME; Chen Y
Front Immunol; 2023; 14():1215855. PubMed ID: 37554327
[TBL] [Abstract][Full Text] [Related]
7. Role of macrophages in regression of myocardial fibrosis following alleviation of left ventricular pressure overload.
Neff LS; Biggs RM; Zhang Y; Van Laer AO; Baicu CF; Subramanian S; Berto S; DeLeon-Pennell K; Zile MR; Bradshaw AD
Am J Physiol Heart Circ Physiol; 2024 May; 326(5):H1204-H1218. PubMed ID: 38363214
[TBL] [Abstract][Full Text] [Related]
8. Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner.
Carrillo-Salinas FJ; Anastasiou M; Ngwenyama N; Kaur K; Tai A; Smolgovsky SA; Jetton D; Aronovitz M; Alcaide P
Gut Microbes; 2020 Nov; 12(1):1-20. PubMed ID: 33103561
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin 1 aggravates hypertrophic heart failure caused by pressure overload via shifting energy metabolism.
Van Le TN; Zoungrana LI; Wang H; Fatmi MK; Ren D; Krause-Hauch M; Li J
Biochem Biophys Res Commun; 2022 Dec; 637():170-180. PubMed ID: 36403480
[TBL] [Abstract][Full Text] [Related]
10. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.
Coelho-Filho OR; Shah RV; Mitchell R; Neilan TG; Moreno H; Simonson B; Kwong R; Rosenzweig A; Das S; Jerosch-Herold M
Circulation; 2013 Sep; 128(11):1225-33. PubMed ID: 23912910
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF).
Cho S; Dadson K; Sung HK; Ayansola O; Mirzaesmaeili A; Noskovicova N; Zhao Y; Cheung K; Radisic M; Hinz B; Sater AAA; Hsu HH; Lopaschuk GD; Sweeney G
Biomed Pharmacother; 2024 Feb; 171():116119. PubMed ID: 38181714
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of resveratrol against pressure overload-induced heart failure.
Gupta PK; DiPette DJ; Supowit SC
Food Sci Nutr; 2014 May; 2(3):218-29. PubMed ID: 24936291
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice.
Fletcher EK; Ngwenyama N; Nguyen N; Turner SE; Covic L; Alcaide P; Kuliopulos A
Circ Heart Fail; 2023 Oct; 16(10):e010621. PubMed ID: 37477012
[TBL] [Abstract][Full Text] [Related]
14. A feasibility study of [18F]F-AraG positron emission tomography (PET) for cardiac imaging - myocardial viability in ischemia-reperfusion injury model.
Shrestha U; Chae HD; Fang Q; Lee RJ; Packiasamy J; Huynh L; Blecha J; Huynh TL; VanBrocklin HF; Levi J; Seo Y
Res Sq; 2024 Apr; ():. PubMed ID: 38746162
[TBL] [Abstract][Full Text] [Related]
15. Cardiac radiation improves ventricular function in mice and humans with cardiomyopathy.
Pedersen LN; Valenzuela Ripoll C; Ozcan M; Guo Z; Lotfinaghsh A; Zhang S; Ng S; Weinheimer C; Nigro J; Kovacs A; Diab A; Klaas A; Grogan F; Cho Y; Ataran A; Luehmann H; Heck A; Kolb K; Strong L; Navara R; Walls GM; Hugo G; Samson P; Cooper D; Reynoso FJ; Schwarz JK; Moore K; Lavine K; Rentschler SL; Liu Y; Woodard PK; Robinson C; Cuculich PS; Bergom C; Javaheri A
Med; 2023 Dec; 4(12):928-943.e5. PubMed ID: 38029754
[TBL] [Abstract][Full Text] [Related]
16. Alamandine attenuates oxidative stress in the right carotid following transverse aortic constriction in mice.
de Lima Sanches B; Souza-Neto F; de Alcântara-Leonídeo TC; Silva MM; Guatimosim S; Vieira MAR; Santos RAS; da Silva RF
Peptides; 2024 Jan; 171():171094. PubMed ID: 37696437
[TBL] [Abstract][Full Text] [Related]
17. Exogenous Cardiac Bridging Integrator 1 Benefits Mouse Hearts With Pre-existing Pressure Overload-Induced Heart Failure.
Li J; Agvanian S; Zhou K; Shaw RM; Hong T
Front Physiol; 2020; 11():708. PubMed ID: 32670093
[No Abstract] [Full Text] [Related]
18. Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy.
Tavakoli R; Nemska S; Jamshidi P; Gassmann M; Frossard N
J Vis Exp; 2017 Sep; (127):. PubMed ID: 28994784
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal arrhythmogenic remodelling in a mouse model of longstanding pressure overload.
Boulaksil M; Noorman M; Engelen MA; van Veen TA; Vos MA; de Bakker JM; van Rijen HV
Neth Heart J; 2010 Oct; 18(10):509-15. PubMed ID: 20978597
[TBL] [Abstract][Full Text] [Related]
20. RUNX1 facilitates heart failure progression through regulating TGF-β-induced cardiac remodeling.
Qi P; Zhai Q; Zhang X
PeerJ; 2023; 11():e16202. PubMed ID: 37927796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
